PharmaCyte Biotech Inc (PMCB)

US · Healthcare · Biotechnology

$0.42+1.87%

Last close · 2026-09-17

Latest quarter · ended 2026-04-30

Revenue

Net profit

$-4.4M

Profit YoY

-137.4%

EPS

$-0.01

Market cap

$4.2M

Forward P/E

7.0

P/B

0.14

Book value

$3.14

EPS (TTM)

$-2.77

52-week high

$1.51

52-week low

$0.35

50-day MA

$0.57

200-day MA

$0.73

Beta

0.66

Insiders

5.74%

Institutions

7.11%

Fund	Stake
Citadel Advisors Llc	2.64%
Geode Capital Management, LLC	1.82%
Renaissance Technologies Corp	0.53%
XTX Topco Ltd	0.49%
Vanguard Capital Management, LLC	0.48%
Virtu Financial LLC	0.35%
Northern Trust Corp	0.33%
Schonfeld Strategic Advisors LLC	0.25%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for PharmaCyte Biotech Inc — free to start.

Data updated 2026-09-18.